Ace Therapeutics offers a variety of spontaneous diabetic animal models with a focus on physiological relevance, predictive validity, and ethical considerations.
Developing spontaneous diabetic animal models involves selecting species of animals that naturally develop diabetes. These models can be identified through extensive breeding programs and careful phenotypic screening. Our rigorous selection process ensures the development of reliable and reproducible models.
Advantages of Spontaneous Diabetes Models | |
---|---|
|
These models closely mimic the natural onset and progression of diabetes in humans. |
|
The relatively stable process of diabetes onset and progression in spontaneous animal models can better reflect and the natural course of the disease. |
|
Spontaneous models often align better with ethical standards, as they do not involve chemical or surgical treatments. |
Ace Therapeutics offers comprehensive range of spontaneous models including spontaneous models of type 1 diabetes mellitus (T1DM), spontaneous models of type 2 diabetes mellitus (T2DM), spontaneous models of gestational diabetes mellitus (GDM), and spontaneous models of diabetic complications
Spontaneous Models of T1DM
Ace Therapeutics offers custom development services for spontaneous models of T1DM, tailored to your specific research needs. Our models are available for studying the autoimmune aspects of T1DM and testing immunomodulatory therapies. Our models including
Spontaneous Models of T2DM
We provide custom development of spontaneous models of T2DM across different species. These models are designed to study the metabolic mechanisms of type 2 diabetes and evaluate glucose-lowering drugs.
Spontaneous Models of GDM
Ace Therapeutics offers custom development services of spontaneous models for GDM. Our model development services help to understand the pathogenesis of gestational diabetes mellitus and evaluate the safety and efficacy of therapeutic agents for GDM.
Spontaneous Models of Diabetic Complications
We also provide custom development services of spontaneous models for diabetic complications, such as nephropathy, neuropathy, and retinopathy.
Comprehensive Services for Diabetes Mellitus Research
We provide one-stop service for spontaneous models of diabetes. Our services include evaluation of diabetes-related parameters and cellular biomarkers, specific bioassays, organ sampling, pharmacokinetic studies using rodent metabolic cages, as well as customized research solutions tailored to your needs!
For additional information about how our services can be customized to meet your exact needs, please contact us.
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.